It just takes planning, understanding the potential culprits, and working with your healthcare provider
This supplement is not a treatment for BPH, prostate cancer or any disease
What clinical trials are investigating GLP-1 for Alzheimer's disease
Do not use GLP-1 medications if you or any family member has a history of: Medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Seek immediate medical attention if you experience: A lump or swelling in your neck, trouble swallowing, hoarseness, or shortness of breath Severe abdominal pain that does not go away (possible pancreatitis) Signs of allergic reaction including swelling of face, lips, tongue, or throat Symptoms of low blood sugar (dizziness, confusion, rapid heartbeat, sweating) Changes in vision (particularly if you have diabetic retinopathy) Pain in upper stomach, fever, or yellowing of skin or eyes (possible gallbladder issues) Dosing Accuracy Matters With Compounded Vials FDA has warned about dosing errors with compounded injectable semaglutide, including cases where patients or clinicians miscalculated dose conversions (for example, milligrams to units or milliliters)

Further information on MTC and MEN2 can be found at our sister charity AMEND Mounjaro in Other Neuroendocrine Cancers (NETs/NECs) No known or identified risk found However, caution and an individual assessment of use is recommended, due to potential side effects that may exacerbate neuroendocrine cancer-related symptoms or or interact with treatments
Research Use Limitation Used solely for in vitro experiments Not permitted for clinical trials involving humans Not permitted for human or veterinary administration Not permitted for investigational human use Independently verified by Liquilabs s.r.o